(LM)
.
++
GFR and RPF was significantly low in CHO and normal in STZI compared to C. GFR and RPF was high in Px compared to C but not significant. There was significant proteinuria (P) in CHO, STZI, and Px. In 415 STZI and 315 Px LM chan~e consisted of basement membrane thickenin and increase in mesangial matrix. LM changes and P in STZI and fix suggest D nephropathy. This study also suggests that structural changes (SC) can precede R dysfunction eTg. STZ and Px or vice-versa e.g. CHO. Early I therapy did not prevent SC in STZ or Px, most probably due to inadequate D control. * P 4 .05.
RENAL OSTEODYSTROPHY
PAEDIATRIC RENAL OSTEODYSTROPHY: Hodson,E. 81 E.; Dunstan,C.U.; Hills,E.E.; Evans,R.A.
Royal Alexandra Hospital for Children & Concord Hospital, Sydney, N.S.W., Australia. To determine the prevalrnce of renal osteodystrophy 4 7 children, aged 1-17 y r s , with glomerular filtration r a t e s ( G F R ) < 8 0 m l / m i n / 1 . 7 3 m 2 underwent bone biopsies after double tetracycline labelling. Histological parameters in undecalcified sections were measured by a digitizer interfaced to a computer. Control data was from 9 children, aged 1-14 yrs. Hyperparathyroid bone disease(HPD) & osteomalacia(0M) were diagnosed by increases in resorbing surface & decreases in mineralization front respectively.
In group 1 (GFU) 30ml/min/1.73m2:16 children), 4 children had increased osteoid surfaces. Changes in ott.er histological parameters were not seen. In group 2 (GFR 20-29m1/ min/1.73m2). 3 children had HPD.
In group 3 (GFR< 20ml/min/1.73m2:23 children), 12 children had HPD, 2 OM & 9 mixed disease(MD).
X-rays & alkaline phosphatase levels were normal in 10 children with histological changes (HPD 6 , OM I , MD 3 ) . Parathyroid hormone levels were elevated in 22 children with & 10 without histological changes. Serum calcium, phosphorus & bicarbonate did not correlate with any histological parameters. Thus renal bone disease was only seen in children wlth GFHs<30ml/min/1.73m2 L was only reliably ~i a g n o s e d by bone tiopsy. Am J Dis Child 134:135,1980) . Using a precise assay, we have 'measured serum 1.25-(OH) D in 27 children with various glomerular (n=15) and tubular (n=ls) diseases, not treated with steroids which reduce 1,25-(OH) D (Chesney et a1 Lancet 11,1123 Lancet 11, ,1978 . Serum was obtained in $he fasting state on usual diet. Levels were compared to age-matched controls (2-16 yr) and in terns of creatinine clearance using the Schwartz formula based on height and serum creatinine.
Group
( Growth arrest and renal osteodystrophy is a major problem in renal insufficiency of children.The present report describes our experiences in managing renal osteodystrophy in 16 children on maintained hemodialysis treatment by using vitamin D3 for 12 to 18 months and in 14 dialyzed children by using 1.25-DHCC for 12months In treatment with vitamin Dj plasma-Ca,alkaline phosphatase and iFTH normalized nearly.Radiographic abnormalities improved.Bone biopsies showed improvement in signs of secondary hyperparathyreodism and ostitis fibrosa,whereas osteomalacia remained unchanged and osteoblast population showed a small reduction.No real increment in body growth was seen.In treatment with 1,25-DHCC alkaline phosphatase and iPTH normalized cmplete1y.Radiographic examinat L o n s revealed marked improvrmrnt.Histologica1 signs of fibroosteoclasia and resorptive defects disappeared but there was no recovery of osteoma1acia.A reduction of osteoblast population and of bone transformation was obvious.l,25-DHCC,also,failed to normalize growth in uremic children.Summarizing,neither vitamin D3 nor 1.25-DHCC can guarantee complete recovery of renal osteodystrophy and growth arrest in uremic children. to the same extent in I11 and V. In comparison to not treated animals (I), growth rate was significantly better in I11 and V for both weight (111 and V:p<O.Ol) and length (I11 and V: pC0.05), but there was no difference between I11 and V. Conclusion: The present study cannot confirm that 1,25(OH),D, has a more beneficial effect on growth than vitamin D,.
EFFECT OF VITAMIN

